Virtus Biotech ETF (BBP)

Assets	$91.50M
Expense Ratio	0.34%
PE Ratio	n/a
Shares Out	900,004
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	11,957
Open	101.44
Previous Close	99.30
Day's Range	101.38 - 102.92
52-Week Low	58.97
52-Week High	102.81
Beta	0.55
Holdings	70
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus Biotech ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

17.16% of assets

Name	Symbol	Weight
Moderna, Inc.	MRNA	2.08%
Ultragenyx Pharmaceutical Inc.	RARE	1.79%
ImmunityBio, Inc.	IBRX	1.73%
Rhythm Pharmaceuticals, Inc.	RYTM	1.68%
Agios Pharmaceuticals, Inc.	AGIO	1.66%
Precigen, Inc.	PGEN	1.65%
Mirum Pharmaceuticals, Inc.	MIRM	1.65%
Sarepta Therapeutics, Inc.	SRPT	1.64%
Ascendis Pharma A/S	ASND	1.64%
Ligand Pharmaceuticals Incorporated	LGND	1.63%

Performance

BBP had a total return of 70.93% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.56%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Jul 7, 2026

Data Sources Report a data error